Your session is about to expire
← Back to Search
P6 Accupressure Group for Pregnancy
N/A
Waitlist Available
Led By Feyce Peralta, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up delivery of baby
Awards & highlights
Study Summary
This trial will compare if adding pressure point stimulation to standard care can reduce nausea and vomiting during and after surgery for patients having a cesarean section.
Eligible Conditions
- Pregnancy
- Nausea
- Vomiting
- C-Section
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ delivery of baby
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~delivery of baby
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Presence of emesis during scheduled cesarean delivery
Secondary outcome measures
Maternal satisfaction of the IONV/PONV management using a VAS
Number of additional antiemetic rescue medications given postoperatively
Number of antiemetic rescue medications given during the intraoperative period
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: P6 Accupressure GroupActive Control1 Intervention
The pressure point will be stimulated by the presence of the magnet when positioned properly on the P6 acupressure point. Additional pressure may be applied as desired by the study subject but is not necessary for P6 stimulation.
Group II: Sham Pressure PointPlacebo Group1 Intervention
The sham pressure point (distal to the P6 acupressure point).
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,031 Total Patients Enrolled
Feyce Peralta, MDPrincipal InvestigatorNorthwestern University
5 Previous Clinical Trials
441 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are allergic or sensitive to medical adhesives.You are allergic or sensitive to nickel.The baby has died in the womb.You have a pacemaker or defibrillator implanted in your body.
Research Study Groups:
This trial has the following groups:- Group 1: P6 Accupressure Group
- Group 2: Sham Pressure Point
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still open spots for this clinical trial?
"The study is actively searching for volunteers, with the initial posting made on May 26th 2021 and an update to the protocol pushed out in January 11th 2022."
Answered by AI
What is the size of the cohort currently participating in this clinical trial?
"Confirmed. The clinicaltrials.gov website outlines that this investigation, which was initially advertised on May 26th 2021, is ongoing and recruiting for 200 participants from a single location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger